Operator of a biotech company involved in blood bank reagents and antibody production. The company's development includes investigation of the modulation of protein-tyrosine sulfation to treat a variety of diseases with unmet medical needs, enabling research companies to get a strategy to generate monoclonal antibodies using antigens containing tyrosine sulfate.